TABLE 5.
Most common treatment-emergent adverse events in the age and gender study
Group (n) | No. (%) of subjects with the following adverse event:
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Total | Headache | Musculoskeletal pain | Abdominal pain | Fever | Pharyngitis | Constipation | Flatulence | Nausea | |
Posoconazole (51) | 33 (65) | 9 (18) | 6 (12) | 5 (10) | 4 (8) | 4 (8) | 3 (6) | 3 (6) | 2 (4) |
Placebo (18) | 10 (56) | 2 (11) | 0 | 0 | 1 (6) | 0 | 2 (11) | 2 (11) | 4 (22) |